Nancy Fried v. Thomas P Schmalzried

CourtDistrict Court, C.D. California
DecidedMarch 21, 2022
Docket2:22-cv-00434
StatusUnknown

This text of Nancy Fried v. Thomas P Schmalzried (Nancy Fried v. Thomas P Schmalzried) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nancy Fried v. Thomas P Schmalzried, (C.D. Cal. 2022).

Opinion

Case 2:22-cv-00434-JAK-MRW Document 36 Filed 03/21/22 Page 1 of 4 Page ID #:1555

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES – GENERAL

Case No. LA CV22-00434 JAK (MRWx) Date March 21, 2022

Title Nancy Fried v. Thomas P. Schmalzried, et al.

Present: The Honorable JOHN A. KRONSTADT, UNITED STATES DISTRICT JUDGE

T. Jackson-Terrell Not Reported

Deputy Clerk Court Reporter / Recorder

Attorneys Present for Plaintiffs: Attorneys Present for Defendants:

Not Present Not Present

Proceedings: (IN CHAMBERS) ORDER RE DEFENDANTS MEDICAL DEVICE BUSINESS SERVICES, INC., FORMERLY KNOWN AS DEPUY ORTHOPAEDICS, INC. (“DEPUY”); DEPUY SYNTHES SALES, INC. (“DSS”); JOHNSON & JOHNSON; AND JOHNSON & JOHNSON SERVICES, INC.’S MOTION TO STAY CASE (DKT. 14); AND

PLAINTIFF’S MOTION TO REMAND CASE (DKT. 15)

I. Introduction

On November 9, 2021, Nancy Fried (“Fried” or “Plaintiff”) brought this action in the Los Angeles Superior Court, against the following defendants: Thomas P. Schmalzried, Thomas P. Schmalzried, M.D., a professional corporation (collectively, “Schmalzried”); Pinnacle West Orthopaedics (“PWO”); Gregory T. Switzer (“Switzer”); Golden State Orthopaedics, Inc. (“GSO”); and Bradford LaPoint (“LaPoint”).1 Ex. A, Dkt. 15-2 at 4-27. On November 22, 2021, Plaintiff filed a First Amended Complaint (“FAC”), which is the operative one, in which four other defendants were added: Medical Device Business Services, Inc., formerly known as DePuy Orthopaedics, Inc. (“DePuy”); DePuy Synthes Sales, Inc. (“DSS”); Johnson & Johnson; and Johnson & Johnson Services, Inc.2 Ex. 4, Dkt. 1-4 at 13, ¶¶ 5-41. The FAC advances the following six state-law causes of action arising from an allegedly defective hip implant system, the Pinnacle Hip System implant (“Pinnacle Implant”), that caused injury to Plaintiff: (1) strict product liability; (2) negligence; (3) fraud; (4) negligent misrepresentation; (5) breach of implied warranty; and (6) breach of express warranty. Id. at 12, ¶¶ 101-145. On January 20, 2022, the Removing Defendants removed the action based on diversity jurisdiction. Dkt. 1.

On January 31, 2022, the Removing Defendants filed a motion to stay the action, on the ground that this case will likely be transferred to a related multi-district litigation proceeding in the Northern District of Texas. Dkt. 14 (“Motion to Stay”). On February 9, 2022, Plaintiff filed an opposition. Dkt. 18. On February 28, 2022, the Removing Defendants filed a reply. Dkt 27.

1 PWO, Switzer, GSO and LaPoint are referred to collectively as the “Distributor Defendants.” 2 DePuy, DSS, Johnson & Johnson and Johnson & Johnson Services, Inc. are referred to collectively as the “Removing Defendants.” All defendants are referred to collectively as “Defendants.” Page 1 of 4 Case 2:22-cv-00434-JAK-MRW Document 36 Filed 03/21/22 Page 2 of 4 Page ID #:1556

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES – GENERAL

On February 2, 2022, Plaintiff filed a motion to remand, arguing that there is no diversity jurisdiction because Defendants’ claim of fraudulent joinder as to the non-diverse Defendants is incorrect. Dkt. 15 (“Motion to Remand”). On February 22, the Removing Defendants filed an opposition. Dkt. 24. On February 28, 2022, Plaintiff filed a reply. Dkt 26.

A hearing on the Motions was held on March 7, 2021, and they were taken under submission. Dkt. 35. For the reasons stated in this Order, the Motion to Stay is GRANTED and the Motion to Remand is deferred because it will become part of the proceedings in MDL 2244 in the Northern District of Texas. II. Factual Background

A. Allegations in the FAC

The FAC alleges that Plaintiff had a surgery in 2009 in California in which the Pinnacle Implant was implanted. Dkt. 1-4 ¶¶ 4, 89. It also alleges that the implant remained in place for approximately 12 years, and that she then had revision surgery in early 2021, due to an alleged defect in the device that resulted in physical injury and pain and suffering. Id. at 93.

The FAC alleges that Defendants designed, manufactured, promoted, marketed and sold the Pinnacle Implant. Id. ¶ 107. The FAC alleges that the Pinnacle Implant was defective and unreasonably dangerous at the time it was placed in the stream of commerce, and that it was insufficiently tested and was not presented with adequate instructions or warnings to inform Plaintiff or her physicians of the associated risks of its use. Id. It is alleged that Defendants knew or should have known of the danger associated with use of the device, but continued to sell the product in conscious or negligent disregard for the rights and safety of patients. Id. ¶¶ 108, 115.

B. The Pinnacle MDL

On May 23, 2011, the Judicial Panel on Multidistrict Litigation (“JPML”) created MDL 2244 (the “MDL”) in the Northern District of Texas (the “MDL Court”) to coordinate all federal cases sharing “factual questions as to whether DePuy’s Pinnacle Acetabular Cup System, a device used in hip replacement surgery, was defectively designed and/or manufactured, and whether defendants failed to provide adequate warnings concerning the device.” In re DePuy Orthopaedics, Inc., Pinnacle Hip Implant Prods. Liab. Litig., 787 F. Supp. 2d 1358, 1360 (J.P.M.L. 2011).

On August 14, 2012, the MDL court issued a standing Order Regarding Cases Removed from State Court. It provides that cases transferred to the MDL with motions for remand pending will be stayed until those motions are addressed. Ex. 1, Dkt. 18-1 at 4. In the opposition to the Motion to Stay, Plaintiff argues that her counsel is involved in several other Pinnacle Implant cases that have been transferred to the MDL, the earliest of which was docketed in the MDL on June 8, 2021. Dkt. 18 at 7. The opposition states that, to date, none of the motions to remand in those cases has been addressed by the MDL Court. Id.

On February 4, 2022, this case was conditionally transferred to the MDL. See Ex. 3, Dkt. 24-1 at 19 (Conditional Transfer Order).

Page 2 of 4 Case 2:22-cv-00434-JAK-MRW Document 36 Filed 03/21/22 Page 3 of 4 Page ID #:1557

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES – GENERAL

C. The Notice of Removal (Dkt. 1)

In the Notice of Removal, the removing Defendants contend that there is diversity jurisdiction in this action because the citizenship of Schmalzried and the Distributor Defendants, i.e., the non-diverse defendants, should be disregarded. Dkt. 1 ¶¶ 19-21. The removing Defendants argue that the joinder of those Defendants was fraudulent. Id. ¶ 20. The removing Defendants argue that there is no reasonable possibility that the state law claims against Schmalzried or the Distributor Defendants will succeed because they are preempted by FDA regulations. Id. ¶ 22. Relying on PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011), and Mut. Pharm. Co. v. Bartlett, 570 U.S. 472 (2013), they argue that state law claims based on failure-to-warn and product-design theories are preempted when brought against non- manufacturers of an FDA-approved product. Id. ¶ 23. III. Analysis

A. Legal Standards

A district court has the ability to order a stay of its judicial proceedings pending reexamination. This authority is part of its “broad discretion to stay proceedings as an incident to its power to control its own docket.” Clinton v. Jones, 520 U.S. 681, 706 (1997); accord Landis v. N. Am.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Landis v. North American Co.
299 U.S. 248 (Supreme Court, 1936)
Clinton v. Jones
520 U.S. 681 (Supreme Court, 1997)
Rivers v. Walt Disney Co.
980 F. Supp. 1358 (C.D. California, 1997)
In Re Depuy Orthopaedics, Inc.
787 F. Supp. 2d 1358 (Judicial Panel on Multidistrict Litigation, 2011)
PLIVA, Inc. v. Mensing
180 L. Ed. 2d 580 (Supreme Court, 2011)
Mut. Pharm. Co. v. Bartlett
570 U.S. 472 (Supreme Court, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Nancy Fried v. Thomas P Schmalzried, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nancy-fried-v-thomas-p-schmalzried-cacd-2022.